Synopsis of recent research by authors named "Kiyoko Iwatsuki-Horimoto"
- Kiyoko Iwatsuki-Horimoto's recent research focuses on the development and efficacy of vaccines and antiviral therapies against various strains of influenza and SARS-CoV-2, significantly contributing to the understanding of cross-protective immunity.
- The studies include the successful application of mRNA vaccine candidates in mice to combat different clades of highly pathogenic avian influenza and characterizations of SARS-CoV-2 Omicron variants, as well as the exploration of underlying mechanisms affecting COVID-19 severity in immunocompromised individuals.
- Findings indicate promising results for using combination therapies in treating persistent COVID-19 cases in immunocompromised patients, while also highlighting the role of gut microbiota in the pathogenesis of SARS-CoV-2 infection among people living with HIV.
